Health

UK approves GlaxoSmithKline drug to treat COVID-19

British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe Covid-19 symptoms, with the manufacturer saying it “retains activity” against the new Omicron variant.

For more coronavirus news, visit our dedicated page.

The monoclonal antibody “was found to be safe and effective at reducing the risk of hospitalization and death in people with mild to moderate COVID-19 infection who are at an increased risk of developing severe disease,” said the Medicines and Healthcare products Regulatory Agency (MHRA).

Moderna exec says company could have Omicron booster ready in March

Fauci: First US case of COVID-19 omicron variant identified

Health

‘Just in case’ use of antibiotics was rife during COVID-19, says UN health agency

Antibiotics saw “extensive overuse” globally among hospitalized COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially exacerbating the already serious and growing threat of antimicrobial resistance, the UN World Health Organization (WHO) said on Friday.

Health

Teen alcohol and nicotine use in Europe is up, WHO urges preventive measures

Substance use is on the rise among teenagers in Europe, Central Asia and Canada and girls now match or even exceed boys when it comes to smoking and drinking, the World Health Organization (WHO) said in a new report on Thursday.

Health

Gender therapy review reveals devastating impacts on teens

A top Human Rights Council-appointed expert has welcomed the decision by all health authorities in the United Kingdom to halt the routine use of puberty-blockers offered to children as part of gender transition services, amid a sharp increase more widely in the number of teenage girls seeking such treatment and concerns that it might disrupt brain development.